REGN

REGENERON PHARMACEUTICALS INC

Healthcare | Large Cap

$6.56

EPS Forecast

$3,403

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

$6.56

Revenue Forecast:

$3,403

EPS Surprise Forecast:

$0.595

Revenue Surprise Forecast:

$83

Post-release price volatility - Medium

Post-release Overnight Move:

±5.5%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

88%

Probability of beating revenue consensus:

82%

Probability of beating both EPS & revs consensus:

75%

Probability of missing both EPS & revs consensus:

5%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

1

Beta (β)

Forward Looking Beta (β):

1.04

Earnings volatility

EPS standard deviation:

$1.18

Revenue standard deviation:

$150

As % of share price:

0.16% MEDIUM

As % of market cap:

0.19% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$8.32

Revenue 95th %ile:

$3,640

EPS 75th %ile:

$7.01

Revenue 75th %ile:

$3,470

EPS 25th %ile:

$6.26

Revenue 25th %ile:

$3,347

EPS 5th %ile:

$5.51

Revenue 5th %ile:

$3,215

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

46% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

38% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$13

Bid-ask per Share:

$0.95